The latest in a trend of companies stepping back from cell and gene therapies amid regulatory uncertainty and manufacturing ...

The results strengthen Jiangsu Hengrui’s dominance in the Chinese HCC market, showing potential for camrelizumab and ...

Ventus has entered a multi-year partnership with Roche’s Genentech for the discovery and optimisation of new small-molecule ...

Health Canada has granted conditional approval for Gilead Sciences’ Lyvdelzi for PBC patients who have difficulty with ...

Novo Nordisk will hold a meeting to elect new board members following a disagreement between the board and its majority shareholder.

Merck KGaA could now have a head start in the race to market Precem-TcT, which could become the first widely approved ADC in ...

Gibson, Dunn & Crutcher and White & Case have emerged as the foremost legal advisers for mergers and acquisitions (M&A) in ...

At AAO 2025, EyePoint Pharmaceuticals presented updates on its investigational therapy EYP-1901 (vorolanib) for DME and wAMD.

Morgan Stanley has secured the leading position as a financial adviser by deal value in South & Central America's M&A sector.

JP Morgan and Rothschild & Co have emerged as the top mergers and acquisitions (M&A) financial advisers in the Middle East & ...

In the realm of M&A, Skadden, Arps, Slate, Meagher & Flom, and Veirano Advogados have emerged as the top legal advisers in ...

The EU's Annex 1 regulations promote mutual recognition of inspections and regulatory cooperation while demanding rigorous compliance.